98 results
8-K
EX-3.2
PNT
POINT Biopharma Global Inc.
27 Dec 23
Termination of a Material Definitive Agreement
8:54am
holding together at least a majority of all the shares of the Corporation entitled to vote at the meeting, and shall be held at such date and time … of Incorporation”), a quorum for the transaction of business at any meeting of stockholders shall consist of the holders of record of a majority
8-K
EX-3.1
PNT
POINT Biopharma Global Inc.
27 Dec 23
Termination of a Material Definitive Agreement
8:54am
of the Corporation may be increased or decreased by the affirmative vote of the holders of a majority of the outstanding shares of Common Stock … with or without cause at any time by the affirmative vote of the holders of a majority of the outstanding Common Stock of the Corporation entitled to vote
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
8 Nov 23
Third party tender offer statement (amended)
5:06pm
conditions, including the tender of at least a majority of the outstanding Shares as of the expiration of the tender offer.
Computershare Trust Company
SC 14D9
PNT
POINT Biopharma Global Inc.
13 Oct 23
Tender offer solicitation
7:11am
subsidiary of Lilly, would represent at least a majority of the Shares outstanding as of immediately following the consummation of the Offer (the “Minimum
SC TO-T
EX-99
c5sov46 5lsh
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
9c7dmesiokjzqlfoqc
13 Oct 23
Third party tender offer statement
6:52am
SC14D9C
EX-99.2
hfl lkdxat
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC TO-C
EX-99.1
1vt4gcq 0n
3 Oct 23
Information about tender offer
4:30pm
SC14D9C
EX-2.1
kxudm7 k0k8zq6
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
z1vhhz7qqpopnp
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-99.4
zsfhpf fzdnw8a99
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
bk4ry
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-2.1
dhhvva ydd
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.4
q71cenu3 92cu7sb9
3 Oct 23
Tender and Support Agreement
7:35am
ARS
ryv6n hxx1rg7p
1 May 23
Annual report to shareholders
1:52pm
424B5
icxyd co7
14 Sep 22
Prospectus supplement for primary offering
4:12pm